JAK3 and arthritic joint disease: These results imply that Wj1113 may mitigate arthritis symptoms by suppressing chemokines and proinflammatory factors while boosting the expression of anti‐inflammatory factors, potentially through its modulation of the JAK3 and BTK signaling pathways.